Latest Articles
Cyclana Bio Is Exploring the Extracellular Matrix to Treat Endometriosis - Inside Precision Medicine
Cyclana Bio Is Exploring the Extracellular Matrix to Treat Endometriosis Inside Precision Medicine
Published: June 11, 2026, 6:50 p.m.
ESGN intensifies endometriosis awareness as winners emerge in 10th essay competition - Punch Newspapers
ESGN intensifies endometriosis awareness as winners emerge in 10th essay competition Punch Newspapers
Published: June 11, 2026, 4:22 p.m.
Why does endometriosis takes so long to be diagnosed? - BBC
Why does endometriosis takes so long to be diagnosed? BBC
Published: June 11, 2026, 3:05 p.m.
Medicus Pharma Submits Ind Application for PRECISION-E2 Phase 2A Study of Teverelix in Endometriosis in United Arab Emirates - marketscreener.com
Medicus Pharma Submits Ind Application for PRECISION-E2 Phase 2A Study of Teverelix in Endometriosis in United Arab Emirates marketscreener.com
Published: June 11, 2026, 1:52 p.m.
Endometriosis and Fibroids: Expert Explains Advances Giving Women Less Invasive Treatment Options | Newswise - Newswise
Endometriosis and Fibroids: Expert Explains Advances Giving Women Less Invasive Treatment Options | Newswise Newswise
Published: June 11, 2026, 1:30 p.m.
Medicus Pharma files IND for genomics-enabled endometriosis trial in UAE - Yahoo! Finance Canada
Medicus Pharma files IND for genomics-enabled endometriosis trial in UAE Yahoo! Finance Canada
Published: June 11, 2026, 12:50 p.m.
Endometriosis and fibroids: Expert explains advances giving women less invasive treatment options - Mayo Clinic News Network
Endometriosis and fibroids: Expert explains advances giving women less invasive treatment options Mayo Clinic News Network
Published: June 11, 2026, 12:30 p.m.
Oriva appoints Agnès Arbat as CEO as endometriosis drug enters clinic - The Pharma Letter
Oriva appoints Agnès Arbat as CEO as endometriosis drug enters clinic The Pharma Letter
Published: June 11, 2026, 12:10 p.m.
Medicus Pharma submits IND application for endometriosis trial By Investing.com - Investing.com Nigeria
Medicus Pharma submits IND application for endometriosis trial By Investing.com Investing.com Nigeria
Published: June 11, 2026, 11:58 a.m.
Medicus Pharma submits IND application for endometriosis trial - Investing.com
Medicus Pharma submits IND application for endometriosis trial Investing.com
Published: June 11, 2026, 11:55 a.m.
Link copied to clipboard!